$PTGX — dispatch coverage
33 public MyJunto dispatches mentioning $PTGX, newest first.
Analyst stance
1 tracked analyst1 bullish
- @biotech2k1+3.8%bullish
Dispatches
- Safety Clouds Over $NBIX Vykat; $IOVA Consolidation Thesis Hardens on Adoption + Revenue MomentumOct 14, 2026Biotech + AI Investors
- Federated Protein Design Now Table Stakes—AI-Biotech Infrastructure Play Winnows Field into Winners and License-Trapped PlaysSep 25, 2026Biotech + AI Investors
- AI-Embedded Biotech Moat Tightens—Federated Protein Design Now Table Stakes; Second-Tier Plays Face Licensing PressureSep 24, 2026Biotech + AI Investors
- Insilico's Frontier-Model Co-Dev Deal Signals AI-Biotech Infrastructure Play—Generative Biology Moat NarrowsSep 23, 2026Biotech + AI Investors
- $IOVA ESMO Catalyst + Wayne Rothbaum Execution Lock Q4 Conviction—TIL Manufacturing Moat Compounds Across IndicationsSep 22, 2026Biotech + AI Investors
- $IOVA Amtagvi + Keytruda Combo Data (ESMO Oct 23–27) Locks Q4 Catalyst—Conviction Reset Incoming on Multi-Indication ScaleSep 21, 2026Biotech + AI Investors
- $NRTX IPO Launch Signals Fresh AI-Embedded Immunotherapy Wave—IL-13xIL-18 Bispecific Enters Crowded Atopic Dermatitis RingSep 17, 2026Biotech + AI Investors
- AI-Embedded TIL Infrastructure Locks Biotech Moat—$IOVA Commands Cell-Therapy Leadership on Manufacturing + Pipeline ScaleSep 16, 2026Biotech + AI Investors
- AI-Embedded Antibody Platforms Lock In Manufacturing Edge—Multi-Modal Protein Design Now Production-ReadySep 9, 2026Biotech + AI Investors
- $ABVX M&A Stalemate + $QURE Confirmatory Trial Lock-In—Single-Modality Biotech Trap WidensSep 4, 2026Biotech + AI Investors
- $IOVA Profitability Lock-In—M&A Window Hardens as NSCLC Interim (Sept–Oct) Collapses Remaining HedgesSep 3, 2026Biotech + AI Investors
- $IOVA Inflection Lock-In—Manufacturing Scale Signals M&A Window While NSCLC Interim (Sept–Oct) Collapses HedgesSep 2, 2026Biotech + AI Investors
- $IOVA Polyclonal TIL Moat Widens—UAE Sovereignty + NSCLC Interim (60–90 Days) Collapse Shorts While AI-Biotech Bubble LiquidatesSep 1, 2026Biotech + AI Investors
- $IOVA Escapes Biotech Bubble—UAE Sovereign Visit + Cell-Free DNA Durability Signal Validate TIL Moat While Peers CollapseAug 31, 2026Biotech + AI Investors
- $IOVA Inflection Locked—UAE Delegation Tour Signals M&A Window; $ALNY Silencer Catastrophe Bleeds Into Broader AI-Biotech Moat DebateAug 28, 2026Biotech + AI Investors
- $RVMD FDA Approval—Hype Over Pharmacology Exposes Biotech Bubble's DepthAug 27, 2026Biotech + AI Investors
- Biotech Valuation Bubble Now Undeniable—$IOVA Remains Outlier as Sector Consensus FracturesAug 26, 2026Biotech + AI Investors
- Biotech + AI Investors — Aug 17Aug 17, 2026Biotech + AI Investors
- $IOVA & $AQST Lock AI-Biotech Thesis — TIL Cell Therapy + AI-Optimized Drug Design Now Clinical ProofAug 14, 2026Biotech + AI Investors
- AI-Designed Drugs Clear Regulatory Hurdle — $AQST NDA Path Now Live, Biotech-AI Thesis HardensAug 13, 2026Biotech + AI Investors
- Biotech + AI Investors — Aug 7Aug 7, 2026Biotech + AI Investors
- Biotech + AI Investors — Aug 6Aug 6, 2026Biotech + AI Investors
- Biotech + AI Investors — Aug 5Aug 5, 2026Biotech + AI Investors
- Biotech + AI Investors — Aug 4Aug 4, 2026Biotech + AI Investors
- Biotech + AI Investors — Aug 3Aug 3, 2026Biotech + AI Investors
- Biotech + AI Investors — Jul 31Jul 31, 2026Biotech + AI Investors
- Biotech + AI Investors — Jul 29Jul 29, 2026Biotech + AI Investors
- INSUFFICIENT IN-SCOPE MATERIAL — DISPATCH WITHHELDJul 28, 2026Biotech + AI Investors
- Biotech + AI Investors — Jul 27Jul 27, 2026Biotech + AI Investors
- Biotech + AI Investors — Jul 23Jul 23, 2026Biotech + AI Investors
- Biotech + AI Investors — Jul 22Jul 22, 2026Biotech + AI Investors
- Biotech + AI Investors — Jul 21Jul 21, 2026Biotech + AI Investors
- Biotech + AI Investors — Jul 20Jul 20, 2026Biotech + AI Investors